Plunkett Research Online: Genocea Biosciences Inc

GENOCEA BIOSCIENCES INC (GNCA:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Genocea Biosciences, Inc. is a biopharmaceutical company. It discovers and develops novel vaccines and immunotherapies to address diseases with significant unmet needs. Genocea uses its proprietary discovery platform ATLAS (antigen lead acquisition system) to rapidly design vaccines and immunother.....



Genocea Biosciences Inc
Ticker: GNCA
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 617-876-8191
Fax: 617-876-8192
Address: 100 Acorn Park Drive
Cambridge, MA 02140 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Vaccine Research
ContactsDescription
William ClarkCEO/Director/President
Michael AlfieriCFO/Chief Accounting Officer
See More
Genocea Biosciences, Inc. is a biopharmaceutical company. It discovers and develops novel vaccines and immunotherapies to address diseases with significant unmet needs. Genocea uses its proprietary discovery platform ATLAS (antigen lead acquisition system) to rapidly design vaccines and immunother.....See More See More

Auditor: Ernst & Young LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
ATLAS
GEN-003
GEN-009
GEN-010
GEN-007
GEN-006
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: